Scancell presents positive data from the first stage in its Phase 2 SCOPE trial at the 20th International Congress of the Society for Melanoma Research

To download click here

Friday 10 November 2023 09:30 Categories: Immunobody News Regulatory News SCIB1 Year - 2023